Obesity and Overweight: Developing Drugs and Biological Products for Weight Reduction
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
January 7, 2025
June 4, 2025
d3075b32-e4bf-4368-aa3d-a04e7457ded0
Related Documents
Erosive Esophagitis: Developing Drugs for Treatment
Guidance DocumentSeptember 17, 2025Center for Drug Evaluation and Research
Developing Drugs for Optical Imaging
Guidance DocumentJanuary 7, 2025Center for Drug Evaluation and Research
Mpox: Development of Drugs and Biological Products; Guidance for Industry
Guidance DocumentJanuary 19, 2023Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox